Skip to main content

GoodRx Holdings, Inc.

corporate_fare Company Profile

GoodRx Holdings, Inc.

GDRX·NASDAQ·Technology·CIK 0001809519

GoodRx is a consumer-focused digital healthcare platform in the United States, aiming to help Americans save time and money on medications. The company began with a price comparison tool for prescriptions, providing free access to lower medication prices. This platform processes over 420 billion pricing data points daily, integrating this data into a user-friendly interface that offers dynamic, geographically relevant prescription pricing. It also provides access to negotiated prices through GoodRx codes, usable for prescription savings across the United States. GoodRx's expanded platform now offers price transparency and affordability solutions for generic and brand medications to both consumers and healthcare providers. Its services include other healthcare products and services, such as certain condition-specific end-to-end solutions, telehealth services, and wellness-related content. The company's offerings aim to provide significant savings to consumers and promote greater medication awareness, access, and adherence, faster treatment, and improved patient outcomes. GoodRx serves consumers, healthcare providers, pharmacies, and pharmaceutical manufacturers across the United States.

GoodRx Holdings, Inc. (NASDAQ:GDRX) is a publicly traded company in the Technology sector. Wiseek has independently scored 13 items for GDRX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-10, rated 8/10. Across its 13 most recent items scored 7 or higher, the top rating is 9/10, with 8 rated 8 or above. Recent SEC coverage for GDRX spans 8-K, SCHEDULE 13D/A, 4, 10-Q.

Recent high-impact activity:

  • GoodRx Flags Material Weaknesses in Financial Controls, Files 10-Q Late
  • GoodRx Restates Q1/Q2 2026 Revenue, Flags Material Weaknesses
  • Francisco Partners Converts 7.5M Class B Shares, Sells $9.7M in GoodRx Stock
  • Francisco Partners Sells $5.5M GoodRx Stake, Nearly Exits Position
  • GoodRx Q2 Revenue Beats, Raises 2026 Outlook on Pharma Direct Surge

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$796.85M
Net Income
$30.44M
Diluted EPS
$0.09
Op. Cash Flow
$167.9M
Free Cash Flow
$164.38M
Operating Income
$87.49M
Cash & Equivalents
$261.82M
Total Debt
$488.26M
Debt / Equity
0.79×
Net Margin
3.8%
Shares Outstanding
356.33M sh
Source: 10-K · filed 2026-02-25 · accession 0001809519-26-000031

Short Interest & Short Volume

3.00 days to cover

FINRA reported short interest of 3,574,707 shares in GDRX as of the October 30, 2026 settlement, a 2.7% decrease from the prior period — about 3.0 days to cover at its recent average daily volume. On November 20, 2026, 38.2% of GDRX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)3,574,707 shares as of October 30, 2026
Change vs prior period▼ 2.7%
Days to cover3.00 at avg daily volume of 1,192,041
Daily short volume (FINRA facilities)38.2% of 998,290 shares on November 20, 2026
5-day average short volume47.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with G →
$2.88 -1.37% today
52-week range · as of 2026-11-02 $1.77 – $3.89
Market cap
$996.14M
Volume
2M (1.7× avg)
3-mo avg 1.2M
Live data · 2026-11-21 12:44 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed GDRX - Latest Insights

GDRX
Nov 10, 2026, 6:39 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $3.58
Real-time Price: $2.88 info
Change: -$0.700 (-20%) info
Market Cap: $996.145M info
GDRX
Nov 02, 2026, 4:17 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.55
Real-time Price: $2.88 info
Change: -$0.670 (-19%) info
Market Cap: $996.145M info
GDRX
Aug 26, 2026, 9:24 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $3.48
Real-time Price: $2.88 info
Change: -$0.600 (-17%) info
Market Cap: $996.145M info
GDRX
Aug 26, 2026, 9:20 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $3.48
Real-time Price: $2.88 info
Change: -$0.600 (-17%) info
Market Cap: $996.145M info
GDRX
Aug 05, 2026, 5:09 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $3.43
Real-time Price: $2.88 info
Change: -$0.550 (-16%) info
Market Cap: $996.145M info
GDRX
May 06, 2026, 4:31 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $2.57
Real-time Price: $2.88 info
Change: +$0.3106 (+12%) info
Market Cap: $996.145M info
GDRX
May 06, 2026, 4:15 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.54
Real-time Price: $2.88 info
Change: +$0.340 (+13%) info
Market Cap: $996.145M info
GDRX
May 06, 2026, 4:13 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.54
Real-time Price: $2.88 info
Change: +$0.340 (+13%) info
Market Cap: $996.145M info
GDRX
May 01, 2026, 9:23 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $2.39
Real-time Price: $2.88 info
Change: +$0.490 (+21%) info
Market Cap: $996.145M info
GDRX
Apr 29, 2026, 4:14 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $2.30
Real-time Price: $2.88 info
Change: +$0.580 (+25%) info
Market Cap: $996.145M info
GDRX
Mar 06, 2026, 9:01 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $2.26
Real-time Price: $2.88 info
Change: +$0.620 (+27%) info
Market Cap: $996.145M info
GDRX
Feb 25, 2026, 6:27 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $2.12
Real-time Price: $2.88 info
Change: +$0.765 (+36%) info
Market Cap: $996.145M info
GDRX
Feb 25, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.19
Real-time Price: $2.88 info
Change: +$0.690 (+32%) info
Market Cap: $996.145M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets